Item 4. Controls and Procedures
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures
that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified
in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated
to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15(e) and 15d-15(e) under the Exchange
Act, our Chief Executive Officer and Chief Financial Officer (the “Certifying Officers”) carried out an evaluation of the
effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2024. Based on this evaluation, our
Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as
of March 31, 2024 due to a material weaknesses in our internal controls over financial reporting (“ICFR”). As previously
disclosed, a material weakness exists in the Company’s ICFR related to ineffective controls over period end financial disclosure
and reporting processes, including not timely performing certain reconciliations and the completeness and accuracy of those reconciliations,
and lack of effectiveness of controls over accurate accounting and financial reporting and reviewing the underlying financial statement
elements, and recording incorrect journal entries that also did not have the sufficient review and approval.
Notwithstanding the identified material weaknesses, management,
including the Certifying Officers, believes that the financial statements contained in this Form 10-Q filing fairly present, in all material
respects, our financial condition, results of operations and cash flows for the periods presented in conformity with GAAP.
Material Weakness
A material weakness is a deficiency, or a combination of control deficiencies,
in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or
interim consolidated financial statements will not be prevented or detected on a timely basis.
While preparing the second quarter 2024 financial statements we
identified internal control failures over our review of accounts payable, accrued liabilities, stock compensation, and revenue cutoff
that resulted in material errors being reported in (i) our previously issued financial statements for the fiscal year ended December
31, 2023 included in the Company’s Form 8-K as filed with the Securities and Exchange Commission (the “SEC”) on March
20, 2024 and as amended on March 25, 2024 (the “Form 8-K”); (ii) the Company’s unaudited interim financial statements
for three months ended March 31, 2024, included in the Quarterly Report on Form 10-Q as filed with the SEC on May 16, 2024; and (iii)
the financial statements noted in items (i) and (ii) above included in the Company’s Registration Statement on Form S-1, which
was declared effective by the SEC on May 31, 2024. The Company has corrected these errors in an amendment to (i) the Form 8-K, filed
on August 19, 2024 and (ii) an amendment to its Current Report on Form 10-Q for the quarterly period ended March 31, 2024 filed on August
19, 2024.
While preparing the third quarter 2024 financial statements we
identified internal control failures over our review of revenue and related cost of goods sold cutoff, expense classification, prepaid
expenses and financing agreements that resulted in material errors being reported in (i) our previously issued financial statements for
the fiscal years ended December 31, 2023 and 2022 included in the Company’s Form 8-K as filed with the Securities and Exchange
Commission (the “SEC”) on March 20, 2024 and as amended on March 25, and August 19, 2024 (the “8-K”), (ii) the
Company’s unaudited condensed consolidated interim financial statements for the three months ended March 31, 2024 included in the
Quarterly Report on Form 10-Q/A as filed with the SEC on August 19, 2024 (the “Q1 10-Q”), (iii) the Company’s unaudited
condensed consolidated interim financial statements for the three and six months ended June 30, 2024 included in the Quarterly Report
on Form 10-Q as filed with the SEC on August 19, 2024 (the “Q2 10-Q”, and together with the Q1 10-Q, the “10-Qs”)
and (iv) the financial statements noted in items (i) through (iii) above included in the Company’s Registration Statement on Form
S-1, as amended (the “S-1”), which was declared effective by the SEC on October 1, 2024. The Company has corrected these
errors in an amendment to (i) the Form 8-K, filed on January 23, 2025, (ii) an amendment to its Current Report on Form 10-Q for the quarterly
period ended March 31, 2024, filed on January 23, 2025 and (iii) an amendment to its Current Report on Form 10-Q for the quarterly period
ended June 30, 2024, filed on January 23, 2025.
45
These control deficiencies could result in a misstatement in our accounts
or disclosures that would result in a material misstatement to our financial statements that would not be prevented or detected. Accordingly,
we determined that these control deficiencies constitute material weaknesses.
We are in the early stages of designing and implementing a plan to
remediate the material weaknesses identified.
Management has considered and reviewed the errors which occurred
in revenue and cost of goods sold cutoff, accounts payable, accrued liabilities, stock compensation, expense classification, prepaid
expenses, operating lease cash flow classification and finance lease arrangements. Management has determined that controls are not designed
effectively in these areas. To mitigate future misstatements in these areas management will implement the following procedures at the
end of each reporting period:
1. Accounts
Payable - Review the accounts payable with the executive team to inquire about any invoices
not sent to accounts payable.
2. Accrued
Liabilities - Review the accrued liabilities detail with the executive team to determine
if there are any expenses/liabilities for which the company should accrue an expense which
has not yet been recognized.
3.
Stock Compensation - Review
with the CEO and Legal Counsel the list of stock grants which have been made and ask if there have been any other grants made (paper
issued to employees or vendors) which should be included in the analysis.
4. Classification
of expenses - Review the expense classification with the executive team to determine all
expenses are properly classified.
5. Classification
of finance lease arrangements - Review the financing agreements with the executive team to
determine proper classification of the agreements as debt or finance lease.
6.
Prepaid expenses – Review prepaid
expenses with the executive team to determine if all prepaid expenses have been properly recorded for
future services to be rendered and subsequently amortized.
7.
Revenue and cost of goods
sold cut off – Review revenue and related cost of goods sold with executive team to determine if revenue and related cost of
goods sold is properly recognized.
We cannot assure you that these measures will remediate the material
weaknesses described above. The implementation of these remediation measures is in the early stages and will require validation and testing
of the design and operating effectiveness of our internal controls over a sustained period of financial reporting cycles and, as a result,
the timing of when we will be able to fully remediate the material weaknesses is uncertain. If the steps we take do not remediate the
material weaknesses in a timely manner, there could be a reasonable possibility that these control deficiencies or others may result
in a material misstatement of our annual or interim financial statements that would not be prevented or detected on a timely basis. This,
in turn, could jeopardize our ability to comply with our reporting obligations, limit our ability to access the capital markets and adversely
impact our stock price.
Implementing any appropriate changes to our internal controls may distract
our officers and employees, entail substantial costs to modify our existing processes and take significant time to complete. These changes
may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy, or consequent
inability to produce accurate financial statements on a timely basis, could increase our operating costs and harm our business. In addition,
investors’ perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements
on a timely basis may harm our stock price and make it more difficult for us to effectively market and sell our products and services
to new and existing customers.
If
we identify future deficiencies in our internal control over financial reporting or if we
are unable to comply with the demands that will be placed upon us as a public company, including
the requirements of Section 404 of the Sarbanes-Oxley Act, in a timely or effective manner,
we may be unable to accurately report our financial results, or report them within the timeframes
required by the SEC. We also could become subject to sanctions or investigations by the SEC
or other regulatory authorities. In addition, if we are unable to assert that our internal
control over financial reporting is effective, or if our independent registered public accounting
firm is unable to express an opinion as to the effectiveness of our internal control over
financial reporting when required, investors may lose confidence in the accuracy and completeness
of our financial reports, and we may face restricted access to the capital markets and our
stock price may be adversely affected.
Our current controls and any new controls that we develop may also
become inadequate because of poor design or changes in our business, including increased complexity resulting from any international expansion,
and weaknesses in our disclosure controls and internal control over financial reporting may be discovered in the future. Any failure to
develop or maintain effective controls or any difficulties encountered in their implementation or improvement could cause us to fail to
meet our reporting obligations, result in a restatement of our financial statements for prior periods, undermine investor confidence in
us and adversely affect the trading price of our common stock. In addition, if we are unable to continue to meet these requirements, we
may not be able to remain listed on Nasdaq.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting
(as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period from January 1, 2024 through March 31, 2024 that
has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. Subsequent to March
31, 2024, the Company began working on their remediation plan as described above.
46
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.